How do business interests align with the European political agenda? That was the overarching question of the day at the ‘Europe Today: What Associations Need to Know’ webinar discussion hosted by the American Society of Association Executives and sponsored by Visit Brussels on Tuesday, 9 March. Guest panellists included Nele Devolder, Association Director, Kellen; Marsha Turner, CEO, International Association of Lighting Directors; Susan Danger, CEO, AmCham EU.
Europe Today: Susan Danger shares perspectives at webinar
How do business interests align with the European political agenda? That was the overarching question of the day at the ‘Europe Today: What Associations Need to Know’ webinar discussion hosted by the American Society of Association Executives and sponsored by Visit Brussels on Tuesday, 9 March. Guest panellists included Nele Devolder, Association Director, Kellen; Marsha Turner, CEO, International Association of Lighting Directors; Susan Danger, CEO, AmCham EU.
Following a presentation of the political interactions of the EU’s institutions by Nele Devolders, Marsha Turner took the floor to provide a case study of how her association had been impacted by the COVID-19 context. AmCham EU CEO Susan Danger then offered her perspectives on the EU-US policy agenda. Setting the scene of the ‘interesting times’ that the transatlantic relationship has known since the 2008 Financial Crisis, she talked of the importance of business’ role in identifying the positive narrative surrounding globalism and free trade. She pointed to the 16 million jobs that the transatlantic relationship generates in both the US and the EU as evidence of the benefit that openness has brought to the region. In the context of the new US administration she impressed upon the audience her renewed optimism to reset, refresh and rekindle the transatlantic relationship – especially in light of last week’s announcement to suspend tariffs on aircraft and non-aircraft products.
Related items
:focal())
News
5 May 2026
Simplifying the Foreign Subsidies Regulation
With the Foreign Subsidies Regulation (FSR) under review, now is the moment to ensure it delivers on its objectives without creating unnecessary complexity. The FSR plays an important role in addressing distortive foreign subsidies. However, its broad scope and resource-intensive procedures risk undermining its effectiveness.
The current framework creates significant burdens for investors and contracting authorities managing public procurement processes. Changes to the Implementing Regulation alone would only provide limited value. Simplification will require targeted amendments to the primary legislation.
Read more about proposed amendments that would help refocus the FSR on high-risk cases and support the EU’s competitiveness goals.
:focal())
News
4 May 2026
Discussing financial services with policymakers in Paris and Strasbourg
From Monday, 27 to Wednesday, 29 April, AmCham EU travelled to Paris, France and the European Parliament in Strasbourg, France for a series of meetings on EU financial services policy developments. The delegation engaged with representatives from French and European financial authorities, Members of the European Parliament, Accredited Parliamentary Assistants and Group Policy Advisers, to share business perspectives on the EU’s financial services agenda. Discussions focused on how to improve Europe’s competitiveness, deepen capital markets and create the right conditions for innovation in digital finance. Members also highlighted the need for more coherent and interoperable rules that reduce complexity while encouraging long-term investment through risk-based regulation.
:focal())
News
4 May 2026
Discussing healthcare policy priorities in Strasbourg
On Tuesday, 28 to Wednesday, 29 April, AmCham EU travelled to the European Parliament in Strasbourg, France for a series of meetings with policymakers to discuss ongoing EU healthcare policy initiatives. The delegation met with Members of the European Parliament, Accredited Parliamentary Assistants and Group Policy Advisers, to discuss priorities for the EU’s health agenda. This included exchanges on how to strengthen Europe’s life sciences competitiveness and support resilient supply chains. Members also stressed the need for urgent action to simplify overlapping rules and reduce complexity. They underlined that proportionate, risk-based regulation is essential to support innovation. This approach can also help ensure timely patient access to medicines, medical technologies and diagnostics.
Policy priorities
Insights and advocacy driving Europe’s policy agenda. Our priorities support growth, innovation and a stronger transatlantic economy.
Membership
Connecting business and policymakers to strengthen the voice of American companies in Europe.